Literature DB >> 20922626

18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.

D Divisi1, S Di Tommaso, G Di Leonardo, E Brianzoni, A De Vico, R Crisci.   

Abstract

OBJECTIVE: Aim of the study was to establish a noninvasive method for the preoperative characterisation of a pulmonary nodule when biopsy of the small mass is impossible.
METHODS: From 1 January 2006 to 31 December 2008, we observed 124 asymptomatic patients with a noncalcified single lung nodule highlighted by computerised tomography (CT) of the thorax. Patients were divided into 2 groups: Group A consisted of 57 patients with lesion diameters between 0.5 cm and 0.99 cm; Group B consisted of 67 patients with lesion diameters between 1.0 cm and 1.5 cm. Fibreoptic bronchoscopy was negative for endobronchial neoformation in all patients. The topographic distribution of the lesions advised against CT-guided transthoracic needle biopsy or video-assisted thoracoscopy. All patients had preoperative 18-fluorine fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) associated with CT of the thorax, which was compared with CT for evaluation of the mass.
RESULTS: Postoperative histological diagnosis revealed 54 primary lung cancers, 47 lung metastases and 23 benign lesions. In Group A the sensitivity of 18F-FDG PET/CT and CT was 95 % and 73 % and the specificity was 72 % and 64 %, respectively ( P = 0.000001 for 18F-FDG PET/CT; P = 0.000177 for CT). In Group B the sensitivity of 18F-FDG PET/CT and CT was 95 % and 97 %, and the specificity was 80 % and 87 %, respectively ( P = 0.000001).
CONCLUSIONS: Our study shows that 18F-FDG PET/CT improves the identification and characterisation of potentially malignant pulmonary nodules with a diameter < 1 cm. This technique could be a valid alternative to a surgical approach, currently the main method to investigate indeterminate lung nodules. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20922626     DOI: 10.1055/s-0030-1249945

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  6 in total

Review 1.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

2.  Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis.

Authors:  Yuzhu Jia; Wanfeng Gong; Zhiping Zhang; Gaofeng Tu; Jiapeng Li; Fanfan Xiong; Hongtao Hou; Yunyi Zhang; Meiqian Wu; Liping Zhang
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

3.  ¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.

Authors:  Maria Lucia Calcagni; Silvia Taralli; Fabio Maggi; Vittoria Rufini; Giorgio Treglia; Lucia Leccisotti; Lorenzo Bonomo; Alessandro Giordano
Journal:  World J Surg Oncol       Date:  2012-04-28       Impact factor: 2.754

4.  Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.

Authors:  Asaf Senft; Otto S Hoekstra; Birgit I Witte; C René Leemans; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-09-09       Impact factor: 2.503

5.  The value of 18F-FDG-PET/CT in the diagnosis of solitary pulmonary nodules: A meta-analysis.

Authors:  Zhen-Zhen Li; Ya-Liang Huang; Hong-Jun Song; You-Juan Wang; Yan Huang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

6.  The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.

Authors:  Kun Tang; Ling Wang; Jie Lin; XiangWu Zheng; Yiwei Wu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.